1. About DreamCIS: A Leading CRO in the Biopharmaceutical Industry

DreamCIS is a Contract Research Organization (CRO) specializing in providing comprehensive support for clinical trials, a crucial part of new drug development. From study design and data management to analysis and reporting, DreamCIS plays a vital role in the biopharmaceutical industry’s growth, demonstrating consistent growth alongside the sector.

2. H1 2025: Dissecting the Explosive Growth

DreamCIS achieved remarkable results in the first half of 2025, with a 20% increase in sales and a staggering 220% surge in operating profit. Significantly exceeding market expectations, this performance highlights the robust growth of the CRO market and the company’s exceptional business capabilities. The growth in clinical trial services and successful cost optimization efforts were key drivers of this outstanding performance.

3. Growth Drivers: Technology and New Business Ventures

DreamCIS’s explosive growth is rooted in its solid technological foundation and future-oriented new business strategies. Its proprietary EDC and IWRS systems offer competitive pricing and customized services, further enhanced by the integration of AI technology. The company is also actively pursuing new growth engines through ventures in global licensing of new drugs and medical devices, and the pet and animal pharmaceuticals market.

4. Key Investment Points and Action Plan

  • Strengths: Outstanding performance, growing CRO market, diversified business portfolio, and stable financial structure.
  • Risks: Uncertainties surrounding new businesses, potential for increased competition.
  • Action Plan: Considering DreamCIS’s growth potential, establishing a mid- to long-term investment strategy is recommended. However, continuous monitoring of the progress of new businesses and changes in the market’s competitive landscape is crucial.